Emily McCracken

University of Virginia, Duke Medical Center

Papers

2

Total Citations

31

H-Index

2

About

Emily McCracken is a leading surgical researcher whose work focuses on expanding access to kidney transplantation for high-risk patient populations and improving outcomes in minimally invasive pancreatic surgery. Her most impactful contribution addresses the critical challenge of transplant eligibility for morbidly obese patients with end-stage renal disease. In her highly cited 2021 study, she demonstrated that robot-assisted kidney transplantation is a safe and effective alternative for patients with a BMI over 35—a group traditionally denied surgery due to elevated complication risks. This work, with 17 citations, has helped reshape clinical guidelines and offers a life-saving option to a previously underserved population. McCracken also made significant strides in pancreatic surgery, authoring a 2018 study on surgical site infections in minimally invasive pancreaticoduodenectomies using the ACS NSQIP database, which has garnered 14 citations. Her research bridges the gap between advanced surgical technology and equitable patient care, establishing her as a key voice in transplant and hepatopancreatobiliary surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
31
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐assisted kidney transplantation is a safe alternative approach for morbidly obese patients with end‐stage renal disease
17 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of Virginia, Duke Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago